Skip to main content

Advertisement

Open Peer Review Reports for: Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
19 Jun 2019 Submitted Original manuscript
6 Jul 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 2
6 Jul 2019 Submitted Manuscript version 2
29 Jul 2019 Reviewed Reviewer Report - Soichiro Ishihara
4 Aug 2019 Reviewed Reviewer Report - Takayuki Yoshino
12 Aug 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 3
12 Aug 2019 Submitted Manuscript version 3
26 Aug 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 4
26 Aug 2019 Submitted Manuscript version 4
29 Aug 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 5
29 Aug 2019 Submitted Manuscript version 5
Publishing
2 Sep 2019 Editorially accepted
18 Sep 2019 Article published 10.1186/s12885-019-6122-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement